Dividend
-
-
-
-
-
-
-
ADAR1 Issues Statement on Keros Therapeutics' Troubling 2025 Director Election Results and Insufficient Capital Return Proposal
-
-
-
-
-
-
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

